Story

Gerresheimer Shares Surge Over 12% on €1.5 Billion Asset Sale to Apax Partners

ENTHMSVIIDZHZH-TWJAKOHI
Jul 29, 20261 min read
Gerresheimer Shares Surge Over 12% on €1.5 Billion Asset Sale to Apax Partners

Summary

The pharmaceutical packaging specialist's stock rallied sharply after it announced a deal to sell two plastics divisions, with proceeds aimed at significantly reducing its debt burden.

Text size
Background

Shares of Gerresheimer (GXI) surged more than 12% after the Düsseldorf-based pharmaceutical packaging company announced it will sell two of its plastic packaging divisions to private equity firm Apax Partners for an enterprise value of approximately €1.5 billion.

Details of the Transaction

The deal involves the divestment of two business units:

  • U.S.-based Centor, a manufacturer of prescription drug packaging systems.
  • The company's global Primary Packaging Plastics business.

Together, these divisions generated approximately €570 million in revenue last year and employ around 2,400 people across 16 production sites, according to the company's announcement. The transaction represents a key step in Gerresheimer's strategic and financial restructuring.

Market Impact and Debt Reduction

Sample IUX Markets – In-articleAd

Investor reaction was strongly positive, with the stock climbing to an intraday high of €31.95. The rally reflects market relief over the company's plan to use the proceeds to address its substantial debt load, which stands at approximately €1.9 billion. The share price had been trading near multi-year lows, making it highly responsive to the positive news.

The sale had been anticipated by the market, as Gerresheimer's CEO had previously identified the divestment of Centor as a priority. The execution of the deal provides a clear pathway for the company to strengthen its balance sheet.

Institutional Confidence

Adding to the positive sentiment, a recent regulatory filing disclosed that Goldman Sachs holds a significant voting stake of roughly 19–20% in Gerresheimer. This sizable institutional holding is seen as a vote of confidence in the company's turnaround strategy. The stock's sharp, company-specific move occurred against a backdrop of largely flat broader market indices.

Read next

More on Stocks
Back to latest news

LATEST